2014
DOI: 10.1016/j.ejmech.2014.03.047
|View full text |Cite
|
Sign up to set email alerts
|

Chromones as a privileged scaffold in drug discovery: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
209
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 416 publications
(210 citation statements)
references
References 137 publications
1
209
0
Order By: Relevance
“…Structures of thiochroman-4-ones ( [1][2][3][4][5] and hydrazone derivatives (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22). …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Structures of thiochroman-4-ones ( [1][2][3][4][5] and hydrazone derivatives (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22). …”
Section: Methodsmentioning
confidence: 99%
“…In our search for new chemotherapeutic alternatives to fight leishmaniasis we have explored thiochroman compounds, which could be considered a potential privileged scaffold [5,6] because of its great similarity with the chroman compounds which display a broad range of bioactivities [7]. In addition, numerous hydrazones have been reported to possess interesting biological activities such as antitumoral, antiviral and antiparasitic effects [8][9][10]; some hydrazones also exhibit activity against the parasites that cause malaria, leishmaniasis and Chagas disease [3,[11][12][13][14][15][16][17][18], where the inhibition of proteases and represent the most common mechanism of action for the hydrazones [16,[19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…[70,74] A large variety of 2,3-diarylxanthones 103 result as major products from reactions between polysubstituted 3-bromo-2-styrylchromones and styrenes, mediated by palladium catalysts, in one-pot fashion. The proposed mechanism involves Heck coupling between brominated chromones and styrenes to form 2,3-distyrylchromones, in situ electrocyclization, [1,5]-sigmatropic hydrogen migration to give 3,4-dihydroxanthones and finally oxidation to achieve the corresponding 2,3-diarylxanthones 103. From this reaction it was also possible to isolate 2,3-diaryl-3,4-dihydroxanthone intermediates 104 and 6,7-diaryl-1-hydroxy-9H-xanthen-9-ones 105 when 3-bromo-5-methoxy-2-styrylchromones were used as brominated derivatives (Scheme 26).…”
Section: Miscellaneous Reactionsmentioning
confidence: 99%
“…However, studies conducted by Letcher and Yue in 1992 on the reactivity of 2-SCs with maleic anhydride and with N-phenylmaleimide and extensive spectroscopic characterization established that the adduct structures were those of the isomeric 1,2,3,4-tetrahydro-9H-xanthen-9-ones 57 (Scheme 15). [95,96] The formation of these compounds 57 was the result of a [1,3] proton shift in the formed adducts 56, with the driving force of this isomerization being the stability of the reformed chromone moiety.…”
Section: Cycloadditionmentioning
confidence: 99%
See 1 more Smart Citation